は じ め に 腸管管腔には，腸内細菌や病原体などの外来因子 が存在するのに対し，一層の上皮細胞を隔てた腸管 粘膜固有層には，多様な自然免疫細胞や獲得免疫細 胞が存在する．これまでに，クローン病や潰瘍性大 腸炎といった炎症性腸疾患(IBD)患者において， 腸内細菌に対する免疫系の異常な活性化が報告され ている 1)
The gut is a unique tissue where a refined balance is maintained between immune responses and tolerance to a variety of foreign antigens including food and commensal bacteria. Although activation of T helper (Th) cells, such as Th1 and Th17 cells, is responsible for the host defense against invading pathogens in the gut, inappropriate Th1/Th17 responses cause onset and/ or progression of inflammatory bowel disease (IBD) comprised of two major disorders; ulcerative colitis and Crohn's disease. Therefore, the inflammatory responses by Th1/Th17 cells in the gut are tightly regulated through a number of mechanisms. In the human intestine, several innate immune cell subsets play important roles in the maintenance of the gut homeostasis by controlling adaptive immune responses. We recently identified CD14 + CD163 low cells and CD14 + CD163 high CD160 high cells as Th17-inducing dendritic cells and anti-inflammatory phagocytes, respectively. In addition, the dysfunction of these cell subsets was observed in the patients with IBD. Therefore, it would be an important future issue to analyze the mechanisms underlying regulation of intestinal innate immune cell homeostasis for the development of a novel therapeutic intervention for IBD. 
